NO944245L - Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner - Google Patents

Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner

Info

Publication number
NO944245L
NO944245L NO944245A NO944245A NO944245L NO 944245 L NO944245 L NO 944245L NO 944245 A NO944245 A NO 944245A NO 944245 A NO944245 A NO 944245A NO 944245 L NO944245 L NO 944245L
Authority
NO
Norway
Prior art keywords
preparation
recombinant dna
dna molecules
molecules encoding
vaccines against
Prior art date
Application number
NO944245A
Other languages
English (en)
Norwegian (no)
Other versions
NO944245D0 (no
Inventor
Margaret Graham
Trevor Stanley Smith
Edward Albert Munn
David Patrick Knox
Joanna Jane Oliver
Susan Elisabeth Newton
Original Assignee
Biotech & Biolog Scien Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech & Biolog Scien Res filed Critical Biotech & Biolog Scien Res
Publication of NO944245D0 publication Critical patent/NO944245D0/no
Publication of NO944245L publication Critical patent/NO944245L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO944245A 1992-05-08 1994-11-07 Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner NO944245L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209993A GB9209993D0 (en) 1992-05-08 1992-05-08 Vaccines
PCT/GB1993/000943 WO1993023542A1 (en) 1992-05-08 1993-05-07 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections

Publications (2)

Publication Number Publication Date
NO944245D0 NO944245D0 (no) 1994-11-07
NO944245L true NO944245L (no) 1995-01-06

Family

ID=10715227

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944245A NO944245L (no) 1992-05-08 1994-11-07 Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner

Country Status (25)

Country Link
US (4) US6066503A (pl)
EP (1) EP0640133B1 (pl)
JP (1) JPH07508879A (pl)
CN (1) CN1053699C (pl)
AT (1) ATE195346T1 (pl)
AU (1) AU677582B2 (pl)
BG (1) BG62700B1 (pl)
CA (1) CA2134326A1 (pl)
CZ (1) CZ274494A3 (pl)
DE (1) DE69329195T2 (pl)
DK (1) DK0640133T3 (pl)
ES (1) ES2151506T3 (pl)
FI (1) FI945221A0 (pl)
GB (1) GB9209993D0 (pl)
GR (1) GR3034766T3 (pl)
HU (1) HU218041B (pl)
NO (1) NO944245L (pl)
NZ (1) NZ252221A (pl)
PL (1) PL175900B1 (pl)
PT (1) PT640133E (pl)
RO (1) RO117709B1 (pl)
RU (1) RU2140986C1 (pl)
SK (1) SK132394A3 (pl)
WO (1) WO1993023542A1 (pl)
ZA (1) ZA933216B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099843A (en) * 1991-02-12 2000-08-08 Heska Corporation Parasitic helminth PLA2 proteins
US5972645A (en) * 1991-12-13 1999-10-26 Heska Corporation Flea serine protease nucleic acid molecules
US6150125A (en) * 1991-12-13 2000-11-21 Heska Corporation Flea protease proteins and uses thereof
US6146870A (en) * 1991-12-13 2000-11-14 Heska Corporation Flea protease proteins
US6156556A (en) * 1991-12-13 2000-12-05 Heska Corporation Flea protease proteins, nucleic acid molecules, and uses thereof
US6121035A (en) * 1991-12-13 2000-09-19 Heska Corporation Flea aminopeptidase proteins and uses thereof
US6210920B1 (en) 1991-12-13 2001-04-03 Heska Corporation Flea protease proteins, nucleic acid molecules, and uses thereof
GB9209993D0 (en) * 1992-05-08 1992-06-24 Munn Edward A Vaccines
GB9302302D0 (en) * 1993-02-05 1993-03-24 Pitman Moore Inc Process
GB9303681D0 (en) * 1993-02-24 1993-04-14 Pitman Moore Inc Vaccines
GB9322702D0 (en) 1993-11-03 1993-12-22 Agricultural & Food Res Vaccines
BR9305075A (pt) * 1993-12-16 1995-08-08 Fundacao Oswaldo Cruz Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
US6214579B1 (en) 1994-10-18 2001-04-10 Heska Corporation Flea leucine aminopeptidase nucleic acid molecules and uses thereof
US6204010B1 (en) 1995-06-07 2001-03-20 Heska Corporation Flea protease proteins, nucleic acid molecules, and uses thereof
US6139840A (en) * 1995-10-18 2000-10-31 Heska Corporation Methods of eliciting an antibody response using flea protease proteins and homologs thereof
IL120704A0 (en) * 1996-04-24 1998-04-05 Heska Corp Flea protease proteins nucleic acid molecules and uses thereof
RU2423525C2 (ru) * 2001-02-23 2011-07-10 ДСМ Ай Пи ЭССЕТС Б.В. Новые гены, кодирующие новые протеолитические ферменты
US20040006204A1 (en) 2002-04-02 2004-01-08 Miriam Tendler Synthetic active peptide fragments
US7951557B2 (en) 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
ES2660667T3 (es) 2007-05-07 2018-03-23 Protalix Ltd. Biorreactor desechable a gran escala
US20080294361A1 (en) * 2007-05-24 2008-11-27 Popp Shane M Intelligent execution system for the monitoring and execution of vaccine manufacturing
ES2325243B1 (es) 2008-02-27 2011-05-04 Universidad De Granada Antigeno recombinante.
US9052304B2 (en) 2009-03-13 2015-06-09 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography
CN112961848B (zh) * 2021-02-24 2022-09-09 中国海洋大学 一种新型氨肽酶及其可溶性表达方法
CN119391673B (zh) * 2024-10-21 2025-09-26 新镁(上海)生物技术有限公司 α-L-岩藻糖苷酶突变体及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2183662B (en) 1985-04-01 1989-01-25 Celltech Ltd Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
GB8619293D0 (en) * 1986-08-07 1986-09-17 Munn E A Anthelmintic agents
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
GB8809129D0 (en) 1988-04-18 1988-05-18 Celltech Ltd Recombinant dna methods vectors and host cells
JPH03503054A (ja) * 1988-09-26 1991-07-11 バイオテクノロジー・オーストラリア・プロプライエタリー・リミテッド ワクチン
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens
NL9001832A (nl) * 1990-08-16 1992-03-16 Rijksuniversiteit Specifieke sequenties van dna van een nematode die toegepast kunnen worden bij de diagnostiek van infektie met de nematode.
US5795768A (en) * 1991-02-12 1998-08-18 Heska Corporation Filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
GB9209993D0 (en) * 1992-05-08 1992-06-24 Munn Edward A Vaccines
GB9302302D0 (en) * 1993-02-05 1993-03-24 Pitman Moore Inc Process

Also Published As

Publication number Publication date
AU677582B2 (en) 1997-05-01
PL175900B1 (pl) 1999-03-31
US20080145379A1 (en) 2008-06-19
WO1993023542A1 (en) 1993-11-25
ES2151506T3 (es) 2001-01-01
BG62700B1 (bg) 2000-05-31
PT640133E (pt) 2000-12-29
RU94046017A (ru) 1997-03-20
CA2134326A1 (en) 1993-11-25
AU4077593A (en) 1993-12-13
ZA933216B (en) 1994-06-14
FI945221L (fi) 1994-11-07
SK132394A3 (en) 1995-07-11
ATE195346T1 (de) 2000-08-15
RO117709B1 (ro) 2002-06-28
EP0640133B1 (en) 2000-08-09
CZ274494A3 (en) 1995-08-16
HUT71847A (en) 1996-02-28
NO944245D0 (no) 1994-11-07
BG99246A (bg) 1995-07-28
FI945221A7 (fi) 1994-11-07
DK0640133T3 (da) 2000-12-18
CN1053699C (zh) 2000-06-21
RU2140986C1 (ru) 1999-11-10
JPH07508879A (ja) 1995-10-05
HU218041B (hu) 2000-05-28
DE69329195D1 (de) 2000-09-14
NZ252221A (en) 1996-12-20
CN1084563A (zh) 1994-03-30
FI945221A0 (fi) 1994-11-07
EP0640133A1 (en) 1995-03-01
US6066503A (en) 2000-05-23
US20030078398A1 (en) 2003-04-24
GR3034766T3 (en) 2001-02-28
GB9209993D0 (en) 1992-06-24
US6534638B1 (en) 2003-03-18
DE69329195T2 (de) 2001-04-05

Similar Documents

Publication Publication Date Title
NO944245D0 (no) Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner
DK217288D0 (da) Dna, der indkoder t-celleoverfladeproteinet t4, og anvendelse af t4-fragmenter ved behandling af aids
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
WO1997048370A3 (en) Vaccines comprising synthetic genes
BR0107703A (pt) Flavivìrus recombinantes e processos para uso dos mesmos
ATE280947T1 (de) Funktionelle fragmente des hiv-1 vpr proteins and eine methode zu seiner anwendung
PT84089B (pt) Sequencias de adn codificando para proteinas possuindo a actividade biologica dos inibidores de husi-tipo i, processos biotecnologicos para a preparacao das referidas proteinas e de composicoes farmaceuticas contendo as referidas proteinas
DK1862544T3 (da) Polypeptider, som kan udløse en immunreaktion mod cancer
DK1082423T3 (da) Cyclin E2-gener og -proteiner
BR0206112A (pt) Vacinas de ácido nucléico usando ácidos nucléicos de codificação de antìgeno de tumor com ácido nucleìco de codificação de auxiliar de citocina
WO1998011234A3 (en) Human protein kinases
DE69318716D1 (de) Anti-Katze Immundefiziensvirus (FIV) Impfstoffe
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
AR005750A1 (es) Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion
WO2002008257A3 (en) Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
WO2001092496A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2005049793A3 (en) Methods and compositions for combinatorial approaches to cancer gene therapy
EP0652769A1 (en) Vaccines against Metazoon parasites.
ES2367245T8 (es) Virus recombinante que expresa adn foráneo que codifica cd80 felino, cd28 felino, ctla-4felino o cd86 felino y usos del mismo.
UY26588A1 (es) Mutantes de ehv gm-negativos
WO1998042847A3 (de) Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung
BR9915537A (pt) Gene prv-1 e sua utilização
NO20005321L (no) Vertskodet protein uttrykt i Mareks sykdoms (MDV) infiserte celler og antistoffer til dette
WO2001090328A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002068617A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application